Importantly, the FDA simultaneously announced its intention to consult the Pharmacy Compounding Advisory Committee (PCAC) at a scheduled hearing on July 23, 2026, regarding potentially adding BPC-157 (both acetate and free base forms) to the Category 1 approved list
Side effects : Nausea, gastrointestinal upset, injectionsite reactions, water retention, joint discomfort, or blood sugar changes can occur, depending on the peptide
Some pen injectors publish 28 days in-use stability (Humatrope, Genotropin GoQuick, Saizen click.easy)
That said, there are no known risks of taking Vitamin B in combination with blood pressure medication, as long as you are treating a vitamin deficit and not going above the recommended daily dose